IFN-γ, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG
Search, find, compare suppliers for anti-IFN-γ, Human antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IFN-γ, Human |
| Clone | 45-15 |
| Host Species | Mouse |
| Reactive Species | human, nonhuman primate |
| Isotype | IgG1 |
| Format | purified |
| Size | 500 µg in 0.5 mL |
| Concentration | n/a |
| Applications | Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | IFN-γ Antibody, anti-human, pure-functional grade. Interferon gamma (IFN-γ) is produced by cells that are involved in inflammatory immune responses. IFN-γ is predominantly released by memory and effector CD4+ and CD8+ T cells as well as by NK cells upon activation. Quantitative analysis of IFN-γ-producing cells can provide important information on the course of immune responses. Anti-IFN?γ antibodies are designed for intracellular staining of IFN?γ-producing cells. Cells can be stimulated for IFN-γ-production, e.g. by polyclonal stimulation with mitogens. For induction of IFN?γ-production by antigen-specific T cells, cells are restimulated with respective antigen. IFN?γ can be accumulated in the cells by addition of secretion inhibitors like brefeldin A. After fixation and permeabilization of the cell sample, IFN?γ-producing cells can be stained intracellularly with Anti-IFN?γ antibodies. Staining of surface markers allows simultaneous flow cytometric analysis of subsets and activation status of the IFN-γ-producing cells. |
| Immunogen | n/a |
| Other Names | IFNg, IFG, IFI |
| Gene, Accession # | Gene ID: 3458 |
| Catalog # | 130-095-743 |
| Price | $410 |
| Order / More Info | IFN-γ, Human Antibody from MILTENYI BIOTEC B.V. & Co. KG |
| Product Specific References | Chaput, N. et al. (2013) Phase I clinical trial combining imatinib mesylate and IL-2: HLA-DR+ NK cell levels correlate with disease outcome. Oncoimmunology 2 (2): e23080. |
MILTENYI BIOTEC B.V. & Co. KG
MILTENYI BIOTEC B.V. & Co. KG
Friedrich-Ebert-StraÃe 68
51429 Bergisch Gladbach GERMANY
P: +49 2204 8306-0
F: +49 2204 85197
macs@miltenyibiotec.de
https://www.miltenyibiotec.com
Profile of MILTENYI BIOTEC B.V. & Co. KG
Return to Antibodies